Explore more publications!

Science Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Press Releases.

Press releases published on October 3, 2025

KFSHRC Concludes Successful Participation at 2nd Annual Future of Health Europe Summit
Health Conditions Often Misinterpreted as Attention or Behavior Disorders
Kent Imaging Appoints Chris Tiemann as Vice President of Global Sales Amid Strategic Global Expansion
GenomicMD Launches Integrated Risk Assessment for Coronary Artery Disease to Enhance Cardiovascular Precision Medicine
Eysz, Inc. Awarded NIH SBIR Fast-Track Grant to expand into Remote Monitoring of Childhood Absence Epilepsy
WittKieffer Expands Global Purpose-Built Team for Investor-Backed Healthcare and Life Sciences
Mactores Signs Strategic AWS Partnership to Accelerate Enterprise GenAI Adoption by 80%
Women in Media Spotlight: 'Third Degree Burnout – A Survivor’s Guide' Celebrates LA, Phoenix and Boston Premieres
Datavault AI Selected to Power First Tokenized Dream Bowl XIV and Esports Global Championships on Jan. 11 at AT&T Stadium in Arlington, TX
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Context Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Grupo Aeroportuario del Pacifico Reports a Passenger Traffic Increase in September 2025 of 0.9% Compared to 2024
electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)
Diginex Announces Completion of Acquisition of Matter DK ApS, Strengthening Diginex’s AI-driven ESG Data and Analytics Leadership
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
argenx announces Extraordinary General Meeting of Shareholders on November 18, 2025
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions